Gordon, O., He, Z., Gilon, D., Gruener, S., Pietranico-Cole, S., Oppenheim, A., & Keshet, E. (2014). A transgenic platform for testing drugs intended for reversal of cardiac remodeling identifies a novel 11βHSD1 inhibitor rescuing hypertrophy independently of re-vascularization. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Gordon, Oren, Zhiheng He, Dan Gilon, Sabine Gruener, Sherrie Pietranico-Cole, Amit Oppenheim, et Eli Keshet. A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11βHSD1 Inhibitor Rescuing Hypertrophy Independently of Re-vascularization. Public Library of Science (PLoS), 2014.
Style de citation MLA (8e éd.)Gordon, Oren, et al. A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11βHSD1 Inhibitor Rescuing Hypertrophy Independently of Re-vascularization. Public Library of Science (PLoS), 2014.